Bertz H - Search Results

1

Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.

Carreras E, Bertz H, Arcese W, Vernant JP, Tomás JF, Hagglund H, Bandini G, Esperou H, Russell J, de la Rubia J, Di Girolamo G, Demuynck H, Hartmann O, Clausen J, Ruutu T, Leblond V, Iriondo A, Bosi A, Ben-Bassat I, Koza V, Gratwohl A, Apperley JF. Carreras E, et al. Among authors: bertz h. Blood. 1998 Nov 15;92(10):3599-604. Blood. 1998. PMID: 9808553 Free article.

2

Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS).

Zenz T, Rössle M, Bertz H, Siegerstetter V, Ochs A, Finke J. Zenz T, et al. Among authors: bertz h. Liver. 2001 Feb;21(1):31-6. doi: 10.1034/j.1600-0676.2001.210105.x. Liver. 2001. PMID: 11169070

3

Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation.

Dettenkofer M, Ebner W, Bertz H, Babikir R, Finke J, Frank U, Rüden H, Daschner FD. Dettenkofer M, et al. Among authors: bertz h. Bone Marrow Transplant. 2003 May;31(9):795-801. doi: 10.1038/sj.bmt.1703920. Bone Marrow Transplant. 2003. PMID: 12732887

4

Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies.

Marks R, Potthoff K, Hahn J, Ihorst G, Bertz H, Spyridonidis A, Holler E, Finke JM. Marks R, et al. Among authors: bertz h. Blood. 2008 Jul 15;112(2):415-25. doi: 10.1182/blood-2007-08-104745. Epub 2008 May 1. Blood. 2008. PMID: 18451310 Free article. Clinical Trial.

5

Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease.

Dilger K, Halter J, Bertz H, Lopez-Lazaro L, Gratwohl A, Finke J. Dilger K, et al. Among authors: bertz h. Biol Blood Marrow Transplant. 2009 Mar;15(3):336-43. doi: 10.1016/j.bbmt.2008.12.001. Biol Blood Marrow Transplant. 2009. PMID: 19203724 Free article. Clinical Trial.

6

Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a double-blind, randomized, controlled trial.

Dettenkofer M, Wilson C, Gratwohl A, Schmoor C, Bertz H, Frei R, Heim D, Luft D, Schulz S, Widmer AF. Dettenkofer M, et al. Among authors: bertz h. Clin Microbiol Infect. 2010 Jun;16(6):600-6. doi: 10.1111/j.1469-0691.2009.02917.x. Epub 2009 Aug 17. Clin Microbiol Infect. 2010. PMID: 19686276 Free article. Clinical Trial.

7

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

Finke J, Bethge WA, Schmoor C, Ottinger HD, Stelljes M, Zander AR, Volin L, Ruutu T, Heim DA, Schwerdtfeger R, Kolbe K, Mayer J, Maertens JA, Linkesch W, Holler E, Koza V, Bornhäuser M, Einsele H, Kolb HJ, Bertz H, Egger M, Grishina O, Socié G; ATG-Fresenius Trial Group. Finke J, et al. Among authors: bertz h. Lancet Oncol. 2009 Sep;10(9):855-64. doi: 10.1016/S1470-2045(09)70225-6. Epub 2009 Aug 18. Lancet Oncol. 2009. PMID: 19695955 Clinical Trial.

8

A novel GVHD-prophylaxis with low-dose alemtuzumab in allogeneic sibling or unrelated donor hematopoetic cell transplantation: the feasibility of deescalation.

Bertz H, Spyridonidis A, Wäsch R, Grüllich C, Egger M, Finke J. Bertz H, et al. Biol Blood Marrow Transplant. 2009 Dec;15(12):1563-70. doi: 10.1016/j.bbmt.2009.08.002. Epub 2009 Oct 1. Biol Blood Marrow Transplant. 2009. PMID: 19896080 Free article.

9

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.

Socié G, Schmoor C, Bethge WA, Ottinger HD, Stelljes M, Zander AR, Volin L, Ruutu T, Heim DA, Schwerdtfeger R, Kolbe K, Mayer J, Maertens JA, Linkesch W, Holler E, Koza V, Bornhäuser M, Einsele H, Kolb HJ, Bertz H, Egger M, Grishina O, Finke J; ATG-Fresenius Trial Group. Socié G, et al. Among authors: bertz h. Blood. 2011 Jun 9;117(23):6375-82. doi: 10.1182/blood-2011-01-329821. Epub 2011 Apr 5. Blood. 2011. PMID: 21467544 Free article. Clinical Trial.

10

Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia.

Bertz H, Spyridonidis A, Ihorst G, Engelhardt M, Grüllich C, Wäsch R, Marks R, Finke J. Bertz H, et al. Biol Blood Marrow Transplant. 2012 Jun;18(6):894-902. doi: 10.1016/j.bbmt.2011.11.017. Epub 2011 Nov 20. Biol Blood Marrow Transplant. 2012. PMID: 22108569 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters